Abiraterone has become the first-choice treatment for men with metastatic prostate cancer.
Robert J. Jones, MBChB, PhD
Advertisement
Articles by Robert J. Jones, MBChB, PhD
Advertisement
Latest Updated Articles
COUNTERPOINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate CancerPublished: May 15th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice
2
FDA Approves Revumenib in R/R NPM1-Mutant AML
3
Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment
4
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
5
